Recent Quarter Total Invested
$16.97 M
Recent Quarter Institutional Ownership Percentage
59.43%
Total Invested of Last Quarter
$33.60 M
Ownership Percentage of Last Quarter
63.48%
Bolt Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 3.81 M | $2.86 M | 11.48% | 10.02% |
| VIVO CAPITAL, LLC | 08/14/2024 | 3.52 M | $2.64 M | 0.00% | 9.25% |
| SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 2.75 M | $2.07 M | 0.00% | 7.24% |
| CITADEL ADVISORS LLC | 08/14/2024 | 2.37 M | $1.78 M | -2.00% | 6.22% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2024 | 1.89 M | $1.42 M | 0.00% | 4.97% |
| NEWTYN MANAGEMENT, LLC | 08/14/2024 | 1.36 M | $1.02 M | -19.81% | 3.58% |
| NAN FUNG GROUP HOLDINGS LTD | 08/13/2024 | 1.17 M | $875,214 | 0.00% | 3.07% |
| VANGUARD GROUP INC | 08/13/2024 | 1.07 M | $800,554 | 2.87% | 2.80% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 1.05 M | $786,865 | 0.00% | 2.76% |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 08/13/2024 | 719,546 | $539,659 | 0.00% | 1.89% |
| ACUITAS INVESTMENTS, LLC | 08/05/2024 | 630,507 | $472,880 | 21.73% | 1.66% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 500,000 | $375,000 | 0.00% | 1.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 370,790 | $278,146 | 6.68% | 0.97% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 276,739 | $207,554 | -46.54% | 0.73% |
| BLACKROCK INC. | 08/13/2024 | 267,068 | $200,301 | 4.75% | 0.70% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 185,999 | $139,499 | 3,619.98% | 0.49% |
| MARQUETTE ASSET MANAGEMENT, LLC | 08/14/2024 | 113,797 | $85,348 | 17.71% | 0.30% |
| FMR LLC | 08/13/2024 | 86,613 | $64,960 | 9.78% | 0.23% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 85,200 | $63,900 | -23.38% | 0.22% |
| PRUDENTIAL FINANCIAL INC | 08/13/2024 | 54,400 | $40,800 | 54.55% | 0.14% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 53,886 | $40,415 | 126.28% | 0.14% |
| UBS GROUP AG | 08/14/2024 | 48,825 | $36,619 | 301.16% | 0.13% |
| STATE STREET CORP | 08/14/2024 | 47,437 | $35,578 | 0.00% | 0.12% |
| JANE STREET GROUP, LLC | 08/15/2024 | 41,528 | $31,146 | 100.00% | 0.11% |
| NORTHERN TRUST CORP | 08/14/2024 | 40,895 | $30,671 | -0.27% | 0.11% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 34,488 | $25,866 | 100.00% | 0.09% |
| MORGAN STANLEY | 08/14/2024 | 33,687 | $25,266 | 36.46% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 22,410 | $16,808 | 100.00% | 0.06% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 15,000 | $11,250 | 0.00% | 0.04% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/08/2024 | 1,000 | $750 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 840 | $630 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 628 | $471 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 184 | $138 | -96.68% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 07/11/2024 | 40 | $30 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 2 | $2 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
Bolt Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of BOLT shares?
During the previous two years, 46 institutional investors and hedge funds held shares of Bolt Biotherapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 3.81 M
Vivo Capital, LLC: 3.52 M
Sofinnova Investments, Inc.: 2.75 M
CITADEL ADVISORS LLC: 2.37 M
Pivotal bioVenture Partners Investment Advisor LLC: 1.89 M
Newtyn Management, LLC: 1.36 M
-
What percentage of Bolt Biotherapeutics, Inc. stock is owned by institutional investors?
59.43% of Bolt Biotherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at BOLT ?
Institutional investors have bought a total of 23.25 M shares in the last 24 months. This purchase volume represents approximately $15.11 M in transactions.